Success Story: Overcoming an RFE to Achieve Success: NAILG Achieves NIW Approval for Researcher Advancing Cancer Treatment Innovation

Client’s Testimonial:

“Thank you very much for your dedicated work.”

On January 11^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the field of Medical Science (Approval Notice).

General Field: Medical Science

Position at the Time of Case Filing: Researcher

Country of Origin: Vietnam

Country of Residence at the Time of Filing: Japan

Approval Notice Date: January 11^th, 2025

Processing Time: 9 months, 27 days (Premium Processing Requested)

Case Summary:

A talented medical scientist has secured EB-2 NIW (National Interest Waiver) approval with the assistance of NAILG after overcoming a Request for Evidence (RFE). Her work focuses on investigating molecular pathways involved in tumor proliferation, aiming to develop targeted inhibitors and antibodies that can slow or prevent cancer progression. This approval, received after 9 months and 27 days of processing, reflects both the significance of her contributions and NAILG’s strong legal strategy in addressing the government’s concerns with clarity and precision.

Pioneering Cancer Research with National Impact
The petitioner, holding a Ph.D. in Medical Science, has built her career around uncovering the cellular and molecular mechanisms that drive cancer development. By analyzing immune cell mutations and their role in tumor growth, her research has contributed to the development of targeted therapies designed to improve the survival and quality of life of cancer patients. Her findings not only advance scientific understanding but also align with national priorities for precision medicine and cost-effective healthcare innovation in the United States.

Academic Achievements and Research Influence
The petitioner has authored six peer-reviewed journal articles (including three as first author) and one abstract, which together have been cited 42 times by independent researchers. Notably, two of her papers rank among the top 10% most-cited publications in clinical medicine for their respective years, underscoring her influence in the global medical research community.

Contributions Recognized by the Scientific Community
Her investigations into immune cells and markers in stem cell transplantation have provided new insights into cancer progression and treatment resistance. Through these studies, she has revealed molecular mechanisms that could inform the design of next-generation cancer therapies and improve patient monitoring in clinical settings. As one expert stated:

“[Client]’s work has been especially important to the continued development of cancer treatments around the world.”

Research Supported by Prestigious Institutions
The significance of her work is further validated by funding from leading organizations such as the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Scientific Research, the MSD Life Science Foundation, and the Princess Takamatsu Cancer Research Fund, among others. These competitive grants highlight the high regard for her contributions within the international scientific community and their relevance to advancing public health.

NIW Approval and Outlook
This NIW approval, achieved despite the issuance of an RFE, demonstrates NAILG’s ability to craft persuasive, evidence-based responses that effectively address USCIS inquiries. Through this petition, NAILG underscored the petitioner’s vital role in advancing cancer research and her capacity to contribute meaningfully to U.S. medical innovation. Her continuing work on tumor biology and targeted therapies is expected to further support national goals in biomedical research and cancer care, reflecting both her dedication and NAILG’s commitment to championing scientists whose research carries global impact.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.